• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Vision quality is patients' top priority when choosing products

Article

Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

Rochester, NY-Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

The NSIGHT study, commissioned by Bausch + Lomb and conducted by Market Probe: Europe, an independent market research firm, surveyed 3,800 spectacle- and contact lens-wearing patients aged 15 to 65 years, from seven countries (China, Korea, Japan, France, Italy, the United Kingdom, and the United States). It aimed to determine a hierarchy of patient needs in the selection of eye-related products, based on respondents’ scoring of 40 features representing eight categories of potential product features.

The study revealed that product benefits relating to vision quality are highly important to patients all around the world. When patients are asked to trade off various functional needs relative to eye-care products, comfort becomes only half as important as vision quality.

The eight categories of eye-care product benefits, in descending order of importance to patients, were vision, health, environment, eye condition, convenience, comfort, personal performance, and personal appearance.

"NSIGHT validated that clear, crisp vision is a top priority for our patients,” said Carla Mack, OD, FAAO, director, global medical affairs, Bausch + Lomb.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.